Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has announcements
×
Urinary Bladder Neoplasms
×
Gemcitabine
×
Clear all
Filters
3
NCT03732677
2026-03-13
NIAGARA
AstraZeneca
Phase 3
Active not recruiting
1,063 enrolled
15 charts
1 FDA
NCT03288545
2025-11-10
EV-103
Astellas Pharma Inc
Phase 1/2
Active not recruiting
348 enrolled
1 FDA